Ebben H P, Yang H T, Hoksbergen A W J, Wisselink W, Ko P J, Yeung K K
Department of Surgery, VU University Medical Center, Amsterdam, the Netherlands.
Section of Vascular Surgery, Chang Gung Memorial Hospital, Taipei, Taiwan.
Ann Vasc Surg. 2019 Feb;55:246-250. doi: 10.1016/j.avsg.2018.07.042. Epub 2018 Sep 29.
The incidence of peripheral arterial occlusions in Asian populations is likely to increase exponentially in the present and future decades due to the adapted Western lifestyle in metropolitan Asian life, extended life expectancies, and high rates of smoking. The literature on thrombolytic treatment of peripheral arterial occlusions in Asian populations is limited. Therefore, we evaluated the thrombolysis results in a real-world contemporary Asian cohort of patients with peripheral arterial occlusions.
Retrospective review of all electronic patient records of patients who underwent thrombolytic therapy for peripheral arterial occlusions between July 2011 and July 2016 was conducted. Outcomes were angiographic patency, clinical success, bleeding complications, amputation rates, and mortality rates.
In total, 82 patients (median age 66 years, range 34-95) underwent catheter-directed thrombolysis. Median treatment duration was 26 hr (3-209). Angiographic patency and clinical success rates were 64% and 66%, respectively. Bleeding complications occurred in 12% of patients of which 6% were major. Amputation-free rates were 81%, 67%, and 63% for 30 days, 6 months, and 1 year, respectively. In-hospital mortality was 6%.
This study demonstrates that thrombolytic treatment of peripheral arterial occlusions in an Asian patient cohort yields comparable treatment success rates to Western cohorts; however, higher rates of bleeding complications are hazardous and remain a detrimental drawback of this treatment.
由于亚洲大都市人群采用西方生活方式、预期寿命延长以及吸烟率高,在当前和未来几十年中,亚洲人群外周动脉闭塞的发病率可能呈指数级增长。关于亚洲人群外周动脉闭塞溶栓治疗的文献有限。因此,我们评估了在现实世界中当代亚洲外周动脉闭塞患者队列中的溶栓结果。
对2011年7月至2016年7月期间接受外周动脉闭塞溶栓治疗患者的所有电子病历进行回顾性分析。观察指标包括血管造影通畅率、临床成功率、出血并发症、截肢率和死亡率。
共有82例患者(中位年龄66岁,范围34 - 95岁)接受了导管定向溶栓治疗。中位治疗时间为26小时(3 - 209小时)。血管造影通畅率和临床成功率分别为64%和66%。12%的患者发生出血并发症,其中6%为严重出血。30天、6个月和1年的无截肢率分别为81%、67%和63%。住院死亡率为6%。
本研究表明,亚洲患者队列中外周动脉闭塞的溶栓治疗成功率与西方队列相当;然而,较高的出血并发症发生率具有危险性,仍然是这种治疗的一个有害缺点。